Cell Growth & Differentiation, Vol 5, Issue 7 711-721, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development

B Li, N Greenberg, LC Stephens, R Meyn, D Medina and JM Rosen
Department of Cell Biology, Baylor College of Medicine, Houston, Texas.

Regulatory sequences derived from the rat whey acidic protein gene have been used to preferentially overexpress a murine 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice. Several different lines of mice expressing the 172Arg-->Leu mutant p53 displayed an impaired ability to lactate, and the mice expressing the highest levels of mutant p53 were unable to nurse their young. This failure was related to the inhibition of normal lobuloalveolar development that occurred during late pregnancy and a marked decrease in milk protein gene expression at early lactation. Interestingly, immunohistochemical analysis revealed that the mutant p53 was localized predominantly in the cytoplasm of alveolar cells. Ductal development was not overtly impaired in these mice. Expression of the 172Arg-->Leu mutant p53 resulted in radiation-induced apoptosis, and transactivation or repression of the expression of a number of genes, including mdm-2 and proliferating cell nuclear antigen, known properties of wild-type p53. The availability of lines of mice preferentially expressing specific p53 mutants in the mammary gland should facilitate evaluation of the roles of other factors, such as hormones, oncogenes and chemical carcinogens, in the etiology of breast cancer.

This article has been cited by other articles:

				C. Hu, A. Dievart, M. Lupien, E. Calvo, G. Tremblay, and P. Jolicoeur Overexpression of Activated Murine Notch1 and Notch3 in Transgenic Mice Blocks Mammary Gland Development and Induces Mammary Tumors Am. J. Pathol., March 1, 2006; 168(3): 973 - 990. [Abstract] [Full Text] [PDF]

				I. Hernandez, L. A. Maddison, Y. Wei, F. DeMayo, T. Petras, B. Li, J. R. Gingrich, J. M. Rosen, and N. M. Greenberg Prostate-Specific Expression of p53R172L Differentially Regulates p21, Bax, and mdm2 to Inhibit Prostate Cancer Progression and Prolong Survival Mol. Cancer Res., December 1, 2003; 1(14): 1036 - 1047. [Abstract] [Full Text] [PDF]

				S. B. Tepera, P. D. McCrea, and J. M. Rosen A {beta}-catenin survival signal is required for normal lobular development in the mammary gland J. Cell Sci., March 15, 2003; 116(6): 1137 - 1149. [Abstract] [Full Text] [PDF]

				C. A. Zahnow, R. D. Cardiff, R. Laucirica, D. Medina, and J. M. Rosen A Role for CCAAT/Enhancer Binding Protein {beta}-Liver-enriched Inhibitory Protein in Mammary Epithelial Cell Proliferation Cancer Res., January 1, 2001; 61(1): 261 - 269. [Abstract] [Full Text]

				C. ALBANESE, A. T. REUTENS, B. BOUZAHZAH, M. FU, M. D’AMICO, T. LINK, R. NICHOLSON, R. A. DEPINHO, and R. G. PESTELL Sustained mammary gland-directed, ponasterone A-inducible expression in transgenic mice FASEB J, May 1, 2000; 14(7): 877 - 884. [Abstract] [Full Text]

				S. G. Bonnette, F. S. Kittrell, L.C. Stephens, R. E. Meyn, and D. Medina Interactions of apoptosis, proliferation and host age in the regression of the mouse mammary preneoplasia, TM3, carrying an unusual mutation in p53 Carcinogenesis, September 1, 1999; 20(9): 1715 - 1720. [Abstract] [Full Text] [PDF]

				J. C. Byrd, C. Shinn, J. K. Waselenko, E. J. Fuchs, T. A. Lehman, P. L. Nguyen, I. W. Flinn, L. F. Diehl, E. Sausville, and M. R. Grever Flavopiridol Induces Apoptosis in Chronic Lymphocytic Leukemia Cells Via Activation of Caspase-3 Without Evidence of bcl-2 Modulation or Dependence on Functional p53 Blood, November 15, 1998; 92(10): 3804 - 3816. [Abstract] [Full Text] [PDF]